Literature DB >> 6486197

Malignant hyperthermia in pregnancy.

J P Cupryn, A Kennedy, R J Byrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6486197     DOI： 10.1016/s0002-9378(84)90378-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  4 in total

1.  The anaesthetic management of the malignant hyperthermia susceptible parturient.

Authors:  M J Douglas; G H McMorland
Journal:  Can Anaesth Soc J       Date:  1986-05

2.  Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.

Authors:  Phi T Ho; Brendan Carvalho; Eric C Sun; Alex Macario; Edward T Riley
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

Review 3.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

4.  Anaesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient.

Authors:  S J Lucy
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.